These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 24675178
1. Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action. Windisch MP, Jo S, Kim HY, Kim SH, Kim K, Kong S, Jeong H, Ahn S, No Z, Hwang JY. Eur J Med Chem; 2014 May 06; 78():35-42. PubMed ID: 24675178 [Abstract] [Full Text] [Related]
2. Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitors. Hwang JY, Kim HY, Jo S, Park E, Choi J, Kong S, Park DS, Heo JM, Lee JS, Ko Y, Choi I, Cechetto J, Kim J, Lee J, No Z, Windisch MP. Eur J Med Chem; 2013 May 06; 70():315-25. PubMed ID: 24177358 [Abstract] [Full Text] [Related]
3. Identification of a series of 1,3,4-trisubstituted pyrazoles as novel hepatitis C virus entry inhibitors. Hwang JY, Kim HY, Park DS, Choi J, Baek SM, Kim K, Kim S, Seong S, Choi I, Lee HG, Windisch MP, Lee J. Bioorg Med Chem Lett; 2013 Dec 01; 23(23):6467-73. PubMed ID: 24125883 [Abstract] [Full Text] [Related]
4. Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B. Zhang X, Zhang N, Chen G, Turpoff A, Ren H, Takasugi J, Morrill C, Zhu J, Li C, Lennox W, Paget S, Liu Y, Almstead N, Njoroge FG, Gu Z, Komatsu T, Clausen V, Espiritu C, Graci J, Colacino J, Lahser F, Risher N, Weetall M, Nomeir A, Karp GM. Bioorg Med Chem Lett; 2013 Jul 01; 23(13):3947-53. PubMed ID: 23683597 [Abstract] [Full Text] [Related]
5. Discovery of N-(4'-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication. Chen G, Ren H, Turpoff A, Arefolov A, Wilde R, Takasugi J, Khan A, Almstead N, Gu Z, Komatsu T, Freund C, Breslin J, Colacino J, Hedrick J, Weetall M, Karp GM. Bioorg Med Chem Lett; 2013 Jul 01; 23(13):3942-6. PubMed ID: 23683596 [Abstract] [Full Text] [Related]
7. Novel anilinocoumarin derivatives as agents against hepatitis C virus by the induction of IFN-mediated antiviral responses. Peng HK, Chen WC, Lee JC, Yang SY, Tzeng CC, Lin YT, Yang SC. Org Biomol Chem; 2013 Mar 21; 11(11):1858-66. PubMed ID: 23377187 [Abstract] [Full Text] [Related]
9. Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor. Hwang JY, Windisch MP, Jo S, Kim K, Kong S, Kim HC, Kim S, Kim H, Lee ME, Kim Y, Choi J, Park DS, Park E, Kwon J, Nam J, Ahn S, Cechetto J, Kim J, Liuzzi M, No Z, Lee J. Bioorg Med Chem Lett; 2012 Dec 15; 22(24):7297-301. PubMed ID: 23159569 [Abstract] [Full Text] [Related]
15. Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agents. Hwu JR, Singha R, Hong SC, Chang YH, Das AR, Vliegen I, De Clercq E, Neyts J. Antiviral Res; 2008 Feb 15; 77(2):157-62. PubMed ID: 17977606 [Abstract] [Full Text] [Related]
16. Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions. Kim HY, Kong S, Oh S, Yang J, Jo E, Ko Y, Kim SH, Hwang JY, Song R, Windisch MP. Antiviral Res; 2016 May 15; 129():39-46. PubMed ID: 26850830 [Abstract] [Full Text] [Related]
18. Discovery and Optimization of a 4-Aminopiperidine Scaffold for Inhibition of Hepatitis C Virus Assembly. Rolt A, Talley DC, Park SB, Hu Z, Dulcey A, Ma C, Irvin P, Leek M, Wang AQ, Stachulski AV, Xu X, Southall N, Ferrer M, Liang TJ, Marugan JJ. J Med Chem; 2021 Jul 08; 64(13):9431-9443. PubMed ID: 34184537 [Abstract] [Full Text] [Related]